# The Feasibility of Dynamic Liquid Biopsy Monitoring During Neoadjuvant Treatment for EGFR-mutated NSCLC

> **NCT06287593** · NA · NOT_YET_RECRUITING · sponsor: **Zhejiang University** · enrollment: 300 (estimated)

## Conditions studied

- EGF-R Positive Non-Small Cell Lung Cancer

## Interventions

- **OTHER:** ctDNA monitoring

## Key facts

- **NCT ID:** NCT06287593
- **Lead sponsor:** Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-04-15
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2024-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06287593

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06287593, "The Feasibility of Dynamic Liquid Biopsy Monitoring During Neoadjuvant Treatment for EGFR-mutated NSCLC". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06287593. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*